Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa

Sputum isolation of Pseudomonas aeruginosa (PA) is associated with extensive disease in bronchiectasis. It is not known, however, whether infection with P. aeruginosa is the result or the cause of severe disease. We compared spirometry in patients with bronchiectasis before and after infection with P. aeruginosa, with that of patients infected by other organisms. All patients (n=12) with chronic colonization by P. aeruginosa (PA group) were studied. These were compared with other patients with bronchiectasis with no isolations of P. aeruginosa (n=37, non-PA group). In the PA group, forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) were lower than in the non-PA group. The PA group, however, also had lower values at the time of initial colonization with P. aeruginosa than the current values for the non-PA group. Change in FEV1 and FVC over time was faster in the PA group than in the non-PA group. Reduction of FEV1 and FVC over time in the PA group prior to P. aeruginosa colonization was intermediate, not being statistically different from either value above. Our results confirm the association of chronic P. aeruginosa colonization with poor lung function, but conclude that patients with bronchiectasis who become colonized by P. aeruginosa have poorer lung function when first colonized than those colonized by other organisms. Decline in lung function is faster in those chronically colonized by P. aeruginosa than in those colonized by other organisms. It is not clear whether chronic P. aeruginosa colonization causes an accelerated decline in lung function or whether it is simply a marker of those whose lung function is already declining rapidly.

This article has been cited by other articles:

				M. Loebinger, A Shoemark, M Berry, M Kemp, and R Wilson Procalcitonin in stable and unstable patients with bronchiectasis Chronic Respiratory Disease, August 1, 2008; 5(3): 155 - 160. [Abstract] [PDF]

				J. Courtney, M. Kelly, A Watt, L Garske, J Bradley, M Ennis, and J. Elborn Quality of life and inflammation in exacerbations of bronchiectasis Chronic Respiratory Disease, August 1, 2008; 5(3): 161 - 168. [Abstract] [PDF]

				C. Juan, O. Gutierrez, F. Renom, M. Garau, C. Gallegos, S. Alberti, J. L. Perez, and A. Oliver Chronic Respiratory Infections by Mucoid Carbapenemase-Producing Pseudomonas aeruginosa Strains, a New Potential Public Health Problem Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2285 - 2286. [Full Text] [PDF]

				T. F. Murphy, A. L. Brauer, K. Eschberger, P. Lobbins, L. Grove, X. Cai, and S. Sethi Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 853 - 860. [Abstract] [Full Text] [PDF]

				A B Chang and D Bilton Exacerbations in cystic fibrosis: 4 {middle dot} Non-cystic fibrosis bronchiectasis Thorax, March 1, 2008; 63(3): 269 - 276. [Abstract] [Full Text] [PDF]

				M. A. Martinez-Garcia, J.-J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and J. Soriano Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis Chest, November 1, 2007; 132(5): 1565 - 1572. [Abstract] [Full Text] [PDF]

				G. Davies, A. U. Wells, S. Doffman, S. Watanabe, and R. Wilson The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Eur. Respir. J., November 1, 2006; 28(5): 974 - 979. [Abstract] [Full Text] [PDF]

				D. Bilton, N. Henig, B. Morrissey, and M. Gotfried Addition of Inhaled Tobramycin to Ciprofloxacin for Acute Exacerbations of Pseudomonas aeruginosa Infection in Adult Bronchiectasis. Chest, November 1, 2006; 130(5): 1503 - 1510. [Abstract] [Full Text] [PDF]

				J Twiss, A W Stewart, and C A Byrnes Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis Thorax, May 1, 2006; 61(5): 414 - 418. [Abstract] [Full Text] [PDF]

				M. D. Macia, N. Borrell, M. Segura, C. Gomez, J. L. Perez, and A. Oliver Efficacy and Potential for Resistance Selection of Antipseudomonal Treatments in a Mouse Model of Lung Infection by Hypermutable Pseudomonas aeruginosa Antimicrob. Agents Chemother., March 1, 2006; 50(3): 975 - 983. [Abstract] [Full Text] [PDF]

				M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij Guidelines for the management of adult lower respiratory tract infections Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180. [Abstract] [Full Text] [PDF]

				M Wickremasinghe, L J Ozerovitch, G Davies, T Wodehouse, M V Chadwick, S Abdallah, P Shah, and R Wilson Non-tuberculous mycobacteria in patients with bronchiectasis Thorax, December 1, 2005; 60(12): 1045 - 1051. [Abstract] [Full Text] [PDF]

				M. D. Macia, D. Blanquer, B. Togores, J. Sauleda, J. L. Perez, and A. Oliver Hypermutation Is a Key Factor in Development of Multiple-Antimicrobial Resistance in Pseudomonas aeruginosa Strains Causing Chronic Lung Infections Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3382 - 3386. [Abstract] [Full Text] [PDF]

				P. Scheinberg, E. Shore, and on behalf of the PC-TNDS-008 Study Group A Pilot Study of the Safety and Efficacy of Tobramycin Solution for Inhalation in Patients With Severe Bronchiectasis Chest, April 1, 2005; 127(4): 1420 - 1426. [Abstract] [Full Text] [PDF]

				M E. Drobnic, P. Sune, J B. Montoro, A. Ferrer, and R. Orriols Inhaled Tobramycin in Non-Cystic Fibrosis Patients with Bronchiectasis and Chronic Bronchial Infection with Pseudomonas aeruginosa Ann. Pharmacother., January 1, 2005; 39(1): 39 - 44. [Abstract] [Full Text] [PDF]

				M. Dupont, A. Gacouin, H. Lena, S. Lavoue, G. Brinchault, P. Delaval, and R. Thomas Survival of Patients With Bronchiectasis After the First ICU Stay for Respiratory Failure Chest, May 1, 2004; 125(5): 1815 - 1820. [Abstract] [Full Text] [PDF]

				N.G. Koulouris, S. Retsou, E. Kosmas, K. Dimakou, K. Malagari, G. Mantzikopoulos, A. Koutsoukou, J. Milic-Emili, and J. Jordanoglou Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis Eur. Respir. J., May 1, 2003; 21(5): 743 - 748. [Abstract] [Full Text] [PDF]

				K. Kostikas, G. Papatheodorou, K. Ganas, K. Psathakis, P. Panagou, and S. Loukides pH in Expired Breath Condensate of Patients with Inflammatory Airway Diseases Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1364 - 1370. [Abstract] [Full Text] [PDF]

				S. Loukides, D. Bouros, G. Papatheodorou, S. Lachanis, P. Panagou, and N. M. Siafakas Exhaled H2O2 in Steady-State Bronchiectasis : Relationship With Cellular Composition in Induced Sputum, Spirometry, and Extent and Severity of Disease Chest, January 1, 2002; 121(1): 81 - 87. [Abstract] [Full Text] [PDF]

				J Angrill, C Agusti, R de Celis, A Rano, J Gonzalez, T Sole, A Xaubet, R Rodriguez-Roisin, and A Torres Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors Thorax, January 1, 2002; 57(1): 15 - 19. [Abstract] [Full Text] [PDF]

				E Caballero, M-E Drobnic, M-T Perez, J-M Manresa, A Ferrer, and R Orriols Anti-Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosis Thorax, September 1, 2001; 56(9): 669 - 674. [Abstract] [Full Text] [PDF]

				M. C. PASTEUR, S. M. HELLIWELL, S. J. HOUGHTON, S. C. WEBB, J. E. FOWERAKER, R. A. COULDEN, C. D. FLOWER, D. BILTON, and M. T. KEOGAN An Investigation into Causative Factors in Patients with Bronchiectasis Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1277 - 1284. [Abstract] [Full Text] [PDF]

				A. F. BARKER, L. COUCH, S. B. FIEL, M. H. GOTFRIED, J. ILOWITE, K. C. MEYER, A. O'DONNELL, S. A. SAHN, L. J. SMITH, J. O. STEWART, et al. Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 481 - 485. [Abstract] [Full Text] [PDF]

				J.-Y. Wang, P.-R. Hsueh, J.-T. Wang, L.-N. Lee, P.-C. Yang, and K.-T. Luh Recurrent Infections and Chronic Colonization by an Escherichia coli Clone in the Respiratory Tract of a Patient with Severe Cystic Bronchiectasis J. Clin. Microbiol., July 1, 2000; 38(7): 2766 - 2767. [Abstract] [Full Text]

				M. Miravitlles, C. Espinosa, E. Fernandez-Laso, J. A. Martos, J. A. Maldonado, and M. Gallego Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD Chest, July 1, 1999; 116(1): 40 - 46. [Abstract] [Full Text] [PDF]

				I. Pujana, L. Gallego, G. Martín, F. López, J. Canduela, and R. Cisterna Epidemiological Analysis of Sequential Pseudomonas aeruginosa Isolates from Chronic Bronchiectasis Patients without Cystic Fibrosis J. Clin. Microbiol., June 1, 1999; 37(6): 2071 - 2073. [Abstract] [Full Text]

				J. M. PILEWSKI and R. A. FRIZZELL Role of CFTR in Airway Disease Physiol Rev, January 1, 1999; 79(1): 215 - 255. [Abstract] [Full Text] [PDF]

				R. Wilson and R. B Dowling Pseudomonas aeruginosa and other related species Thorax, March 1, 1998; 53(3): 213 - 219. [Full Text]